Business · 21/02/2002
FDA Releases Draft Guidance for Cyclosporine and Tacrolimus Assays
The FDA is releasing a draft guidance document for Cyclosporine and Tacrolimus Assays, which will serve as a special control if the devices are reclassified from class III to class II for transplant patients.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →